updated 4/8/2011 4:17:50 PM ET 2011-04-08T20:17:50

WEST LAFAYETTE, Ind., April 8, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases, announced today that Mike Sherman, chief financial officer of Endocyte, will present at the upcoming BioCentury Future Leaders in the Biotech Industry Conference on Friday, April 15th, 2011, at 1:30 p.m. EDT at the Millennium Broadway Hotel in New York City.

A live audio webcast of the Company's presentation can be accessed at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=ECYT&item_id=3846746 or under "Events & Presentations" in the Investor Relations section of Endocyte's website at www.endocyte.com . The webcast will be archived approximately one hour after the live event and a replay will be available on the Company's website.

About Endocyte

Endocyte is a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. Endocyte uses its proprietary technology to create novel small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized targeted therapies. The company's SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently, and over longer periods of time than would be possible with the untargeted drug alone. The companion imaging diagnostics are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment.

CONTACT: Stephanie Ascher
         Stern Investor Relations, Inc.
         (212) 362-1200
         stephanie@sternir.com
         
         Martina Schwarzkoph, Ph.D.
         Russo Partners, LLC
         (212) 845-4292
         martina.schwarzkopf@russopartnersllc.com

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 5.04%
$30K home equity loan FICO 5.23%
$75K home equity loan FICO 4.66%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.28%
13.27%
Cash Back Cards 17.74%
17.72%
Rewards Cards 17.01%
16.98%
Source: Bankrate.com